<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Einstein (Sao Paulo)</journal-id>
      <journal-id journal-id-type="iso-abbrev">Einstein (Sao Paulo)</journal-id>
      <journal-title-group>
        <journal-title>Einstein</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1679-4508</issn>
      <issn pub-type="epub">2317-6385</issn>
      <publisher>
        <publisher-name>Instituto de Ensino e Pesquisa Albert Einstein</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25993078</article-id>
      <article-id pub-id-type="pmc">4946817</article-id>
      <article-id pub-id-type="publisher-id">S1679-45082015RC2738</article-id>
      <article-id pub-id-type="doi">10.1590/S1679-45082015RC2738</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Preimplantation genetic diagnosis for cystic fibrosis: a case report</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Biazotti</surname>
            <given-names>Maria Cristina Santoro</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pinto</surname>
            <given-names>Walter</given-names>
            <suffix>Junior</suffix>
          </name>
          <xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>de Albuquerque</surname>
            <given-names>Maria Cec&#xED;lia Romano Maciel</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fujihara</surname>
            <given-names>Litsuko Shimabukuro</given-names>
          </name>
          <xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Suganuma</surname>
            <given-names>Cl&#xE1;udia Haru</given-names>
          </name>
          <xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Reigota</surname>
            <given-names>Renata Bednar</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bertuzzo</surname>
            <given-names>Carmen S&#xED;lvia</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>1</label>Hospital Israelita Albert Einstein, S&#xE3;o Paulo, SP, Brazil.</aff>
      <aff id="aff2"><label>2</label>Universidade Estadual de Campinas, Campinas, SP, Brazil.</aff>
      <aff id="aff3"><label>3</label>Centro Cochrane do Brasil, S&#xE3;o Paulo, SP, Brazil.</aff>
      <aff id="aff4"><label>4</label>Centro de Reprodu&#xE7;&#xE3;o Humana Fertivitro, S&#xE3;o Paulo, SP, Brazil.</aff>
      <aff id="aff5"><label>5</label> S&#xEA;mion, Centro de Medicina Reprodutiva, Campinas, SP, Brazil.</aff>
      <author-notes>
        <corresp> Corresponding author: Maria Cristina Santoro Biazotti &#x2212; Avenida Albert Einstein, 627/701 &#x2212; Morumbi &#x2013; Zip Code: 05652-900 &#x2212; S&#xE3;o Paulo, SP, Brazil &#x2212; Phone: (55 11) 2151-9205 &#x2212; E-mail: <email>biazotti@biazotti.com</email></corresp>
      </author-notes>
      <pub-date pub-type="epub-ppub">
        <season>Jan-Mar</season>
        <year>2015</year>
      </pub-date>
      <!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
      <pub-date pub-type="ppub">
        <season>Jan-Mar</season>
        <year>2015</year>
      </pub-date>
      <volume>13</volume>
      <issue>1</issue>
      <fpage>110</fpage>
      <lpage>113</lpage>
      <history>
        <date date-type="received">
          <day>21</day>
          <month>3</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>25</day>
          <month>2</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Cystic fibrosis is an autosomal recessive disorder caused by mutations in the cystic fibrosis transmembrane conductance regulator gene. This disorder produces a variable phenotype including lung disease, pancreatic insufficiency, and meconium ileus plus bilateral agenesis of the vas deferens causing obstructive azoospermia and male infertility. Preimplantation genetic diagnosis is an alternative that allows identification of embryos affected by this or other genetic diseases. We report a case of couple with cystic fibrosis; the woman had the I148 T mutation and the man had the Delta F508 gene mutation. The couple underwent<italic> in vitro </italic>fertilization, associated with preimplantation genetic diagnosis, and with subsequent selection of healthy embryos for uterine transfer. The result was an uneventful pregnancy and delivery of a healthy male baby.</p>
      </abstract>
      <kwd-group>
        <kwd>Cystic fibrosis</kwd>
        <kwd>Fertilization <italic>in vitro</italic></kwd>
        <kwd>Preimplantation genetic diagnosis</kwd>
        <kwd>Case reports</kwd>
      </kwd-group>
      <counts>
        <fig-count count="6"/>
        <table-count count="0"/>
        <equation-count count="0"/>
        <ref-count count="16"/>
        <page-count count="4"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>Assisted reproductive techniques progress each day as a result of improvements in laboratory technology, gametes and embryos culture. The introduction of new drugs to induce ovulation and the enhancement of cryopreservation techniques of gametes and embryos are part of this development.</p>
      <p>These advances may benefit cystic fibrosis carrier couples or those with previous genetic disease with <italic>in vitro</italic> fertilization (IVF) associated to preimplantation genetic diagnosis (PGD), enabling the selection of healthy embryos before intrauterine transference.<sup>(<xref rid="B1" ref-type="bibr">1</xref>)</sup>
</p>
      <sec>
        <title>Preimplantation genetic diagnosis</title>
        <p>The PGD was developed with the aim to provide alternatives for prenatal diagnosis in couples with risk to transmit genetic disease to their offspring. This procedure can be useful in cases of disease associated to sex, chromosome anomalies and disorders involving a single gene.<sup>(<xref rid="B1" ref-type="bibr">1</xref>)</sup>
</p>
        <p>During PGD, couples must undergone IVF, even in cases without indication to conduct this technique (<xref ref-type="fig" rid="f01">Figure 1</xref>). To reduce risks of contamination by parental cells during IVF, it is recommended to use intracytoplasmic sperm injection (ICSI).<sup>(<xref rid="B2" ref-type="bibr">2</xref>) </sup>In the event of fertilization, embryos remain in culture until that one or more cells can be removal and submitted for genetic diagnosis.<sup>(<xref rid="B1" ref-type="bibr">1</xref>)</sup>
</p>
        <p>
<fig id="f01" orientation="portrait" position="float"><label>Figure 1</label><caption><title>Preimplantation genetic diagnosis</title></caption><graphic xlink:href="1679-4508-eins-13-1-110-gf01"/></fig>
</p>
        <p>For PGD, we used techniques based on the polymerase chain reaction (PCR) and molecular cytogenetics. After long-term use, the technique of fluorescent <italic>in situ</italic> hybridization (FISH) has been substituted by array-comparative genomic hybridization (aCGH),<sup>(<xref rid="B3" ref-type="bibr">3</xref>,<xref rid="B4" ref-type="bibr">4</xref>) </sup>which analysis specific amplifications and deletions of the genome. This latter enables the detection of gains and losses of genetic material in specific high resolution regions of genome (<xref rid="B10" ref-type="bibr">10</xref> to 100 times higher than traditional techniques),<sup>(<xref rid="B5" ref-type="bibr">5</xref>)</sup> depending on the analysis platform used. In addition, aCGH provide a more accurate assessment of chromosomal anomalies and gene deletions or rearrangements than FISH.</p>
      </sec>
      <sec>
        <title>Biopsy of embryos</title>
        <p>Embryo biopsy involves removal of one or more cells from the early preimplantation embryo for subsequent genetic investigation. The first case of PGD in human was reported by Handyside et al.<sup>(<xref rid="B6" ref-type="bibr">6</xref>)</sup>
</p>
        <p>After ICSI of oocytes, embryos are cultured for 3rd days, or may be cultured until the blastocyst stage (5th/6th day of culture) to be, after that, submitted to biopsy, without negatively affecting implementation or gestational development.<sup>(<xref rid="B6" ref-type="bibr">6</xref>)</sup> The biopsy is often done on the 3rd day of embryonic development (staging six to eight cells) by the removal of one or two blastomeres from each embryo<sup>(<xref rid="B7" ref-type="bibr">7</xref>)</sup> (<xref ref-type="fig" rid="f02">Figure 2</xref>). One of the advantages of postponing biopsy of embryos until the blastocyst stage, is the possibility of obtaining the larger number of cells (trophoderm) for genetic analysis, therefore, increasing the DNA copy number to improve accuracy of diagnosis.<sup>(<xref rid="B8" ref-type="bibr">8</xref>)</sup>
</p>
        <p>
<fig id="f02" orientation="portrait" position="float"><label>Figure 2</label><caption><title>Biopsy</title></caption><graphic xlink:href="1679-4508-eins-13-1-110-gf02"/></fig>
</p>
      </sec>
      <sec>
        <title>Cystic fibrosis</title>
        <p>Cystic fibrosis (CF) is an autosomal recessive disorder caused by mutations in cystic fibrosis transmembrane conductance regulator (CFTR) gene that affects 1 of each 2,500 newborns.<sup>(<xref rid="B9" ref-type="bibr">9</xref>) </sup>This gene codifies a protein expressed in apical membrane of exocrine epithelia cells.<sup>(<xref rid="B10" ref-type="bibr">10</xref>)</sup> Mutations in CFTR gene produce an variable phenotype, including pulmonary disease, pancreatic disease, meconium ileus<sup>(<xref rid="B11" ref-type="bibr">11</xref>)</sup> and they are also involved in bilateral agenesis of the vas deferens, causing obstructive azoospermia and male infertility<sup>(<xref rid="B12" ref-type="bibr">12</xref>)</sup> (<xref ref-type="fig" rid="f03">Figure 3</xref>).</p>
        <p>
<fig id="f03" orientation="portrait" position="float"><label>Figure 3</label><caption><title>Cystic fibrosis</title></caption><graphic xlink:href="1679-4508-eins-13-1-110-gf03"/></fig>
</p>
      </sec>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>We report a case of 33-year-old woman who did not have children and was first evaluated in March 25, 2004 due to difficulties in becoming pregnant for 2 years. She reported menarche at 11 years of age, regular menstrual cycle and a previous maternal history of breast cancer. Her transvaginal ultrasonography, showed a left paratubal cyst and suggestive imaging of right dermoid cyst measuring 16.0 x 12.0mm, which were stable for 12 months. Laboratorial exams and investigations for fungi and bacterial in vaginal secretions were normal. The patient had the I148 mutation in CF.</p>
      <p>The patient was married for 12 years. Her husband was 33-years-old and had severe oligospermia and varicocele. After he underwent surgical correction, he progressed with improvement of seminal parameters, which sperm concentration increased from 0.75million/mL to 5.48million/mL. In addition, he had Delta F508 mutation in CF.</p>
      <p>In September 2004, the patient underwent IVF/ICSI and seven embryos were obtained. Of these, three were transferred to the patient and four were frozen. Her pregnancy test was positive in October 22, 2004 and the transvaginal ultrasonography showed one gestational sac compatible at 5 weeks of gestation. In December 10, at 11 weeks of gestation, the patient underwent a chorionic villus biopsy that confirmed a male fetus. To assess the Delta F508 mutation, we used the PCR and 12% polyacrylamide gel electrophoresis. The I148T mutation was investigated using PCR with primers involving exon 4. Subsequently, we conduct an enzymatic digestion with Bsrl enzyme. These tests showed that the embryo had the CF mutation.</p>
      <p>Later, the patient progressed to miscarriage and underwent a uterine curettage in May 2005. After that, she was not followed-up for 5 months.</p>
      <p>We observed that the couple had TUB18 and KM19 polymorphisms, which enabled the identification of mutant alleles in future gestations, thereby increasing the possibility of detecting an affected embryo.</p>
      <p>In April 2006, the patient underwent a hysteroscopy for uterine septum resection, secondary to previous curettage. The use of GnRH analogs, antibiotics and polivitaminic was reinstated in May 2006. However, there was a poor response to hypothalamic/hypophysary inhibitory factor.</p>
      <p>In the next stage, we opted use her natural cycle by detecting follicles of 19.0mm of diameter in the right ovary and trilaminar endometrium with 10.0mm in thickeness detected by transvaginal ultrasonography. This was done August 31, 2006.</p>
      <p>Four embryos previously frozen were biopsied using a laser guided technique for opening of zona pellucida, and the blastomeres were genetically assessed. There was no amplifications of primers in the first embryo, which prevented investigation for mutations. The second embryo blastomere had both mutations and, was therefore, a CF carrier. The third embryo blastomere had only the I148T mutation and in the fourth embryo there were no mutations found. The third and fourth embryos were transferred to the patients uterus on September 5, 2006. An echography done in November 6, 2006 showed a gestation compatible with 11 weeks and 5 days by biometry. The fetus presented nuchal translucency within normal ranges. In May 10 2007, the patient underwent cesarean section and gave birth to a male baby weighing 3,320g and with an Apgar score of 8/10 without intercurrences. She breastfed her baby for 2 months and returned to clinic visit 11 months after delivery. The child&#x2019;s laboratorial exams showed polyglobulie and eosinophilia without other changes or complaints.</p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>In recessive autosomal diseases, each parent of the child affected has one copy of a mutated allele. In each pregnancy, the possibility of the child born with the disease is 25%. Those with the disease are asymptomatic and couples become aware of the problem only when they experience this in their children, on his/her family or during previous investigations.<sup>(<xref rid="B13" ref-type="bibr">13</xref>)</sup> For this reason, the PGD associated with IVF/ICSI in a risk situation, seems to be the only way to avoid recurrence.<sup>(<xref rid="B14" ref-type="bibr">14</xref>)</sup>
</p>
      <p>Taylor et al. concluded that laser did not influence biopsy and nor affected the development of the embryo.<sup>(<xref rid="B15" ref-type="bibr">15</xref>)</sup> A study by Keymolen et al. conducted for 11 years at a Medical Genetic Center in Belgium, reported PGD in embryos from 47 couples; CF was the most common indication of these procedures (55% of cases). In their study 461 embryos were submitted to biopsy and among 25 newborns, no child was diagnosed with CF.<sup>(<xref rid="B16" ref-type="bibr">16</xref>)</sup>
</p>
      <p>We report a case of PGD that resulted in the birth of healthy child whose parents had a risk of transmiting CF. The mother had the I148T mutation in CF and the father had the Delta F508 mutation for the same disease. The couple underwent IVF/ICSI procedures, vitrification and devistrification of embryos, PGD and embryo transfer. The pregnancy was confirmed without intercurrences, and male baby was delivery by cesarean section.</p>
      <p>The use of PGD was efficient in detecting CF in the embryos assessed. This was a positive experience and encourages a more frequent use of this technique. In addition, our findings may stimulate the development of PGD protocols for several other genetic disorders.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="B1">
        <label>1</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Harper</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <source>Preimplantation Genetic Diagnosis</source>
          <edition>2a</edition>
          <publisher-loc>Cambridge</publisher-loc>
          <publisher-name>Cambridge University Press</publisher-name>
          <year>2009</year>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <collab>ESHRE Capri Workshop Group</collab>
          </person-group>
          <article-title>Intracytoplasmic sperm injection (ICSI) in 2006: evidence and evolution</article-title>
          <source>Hum Reprod Update</source>
          <year>2007</year>
          <volume>13</volume>
          <issue>6</issue>
          <fpage>515</fpage>
          <lpage>526</lpage>
          <pub-id pub-id-type="pmid">17630396</pub-id>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Simpson</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Rechtsky</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kuliev</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Next-generation sequencing for preimplantation genetic diagnosis</article-title>
          <source>Fertil Steril</source>
          <year>2013</year>
          <volume>99</volume>
          <issue>5</issue>
          <fpage>1203</fpage>
          <lpage>1204</lpage>
          <pub-id pub-id-type="pmid">23414921</pub-id>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mart&#xED;n</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Cervero</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Mir</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Martinez-Conejero</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Pellicer</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sim&#xF3;n</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>The impact of next-generation sequencing technology on preimplantation genetic diagnosis and screening</article-title>
          <source>Fertil Steril</source>
          <year>2013</year>
          <volume>99</volume>
          <issue>4</issue>
          <fpage>1054</fpage>
          <lpage>1061</lpage>
          <comment>Review</comment>
          <comment>Erratum in</comment>
          <source>Fertil Steril</source>
          <year>2013</year>
          <volume>99</volume>
          <issue>6</issue>
          <size units="pages">1798</size>
          <person-group person-group-type="compiler">
            <name>
              <surname>Martinez</surname>
              <given-names>Conejero</given-names>
            </name>
            <name>
              <surname>Antonio</surname>
              <given-names>Jose</given-names>
            </name>
          </person-group>
          <pub-id pub-id-type="pmid">23499002</pub-id>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Theisen</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Microarray-based comparative genomic hybridization (aCGH)</article-title>
          <source>Nature Educ</source>
          <year>2008</year>
          <volume>1</volume>
          <issue>1</issue>
          <size units="pages">45</size>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Handyside</surname>
              <given-names>AH</given-names>
            </name>
            <name>
              <surname>Kontogianni</surname>
              <given-names>EH</given-names>
            </name>
            <name>
              <surname>Hardy</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Winston</surname>
              <given-names>RM</given-names>
            </name>
          </person-group>
          <article-title>Pregnancies from biopsied human preimplantation embryos sexed by Y-specific DNA amplification</article-title>
          <source>Nature</source>
          <year>1990</year>
          <volume>344</volume>
          <issue>6268</issue>
          <fpage>768</fpage>
          <lpage>770</lpage>
          <pub-id pub-id-type="pmid">2330030</pub-id>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Harper</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Boelaert</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Geraedts</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Harton</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Kearns</surname>
              <given-names>WG</given-names>
            </name>
            <name>
              <surname>Moutou</surname>
              <given-names>C</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>ESHRE PGD Consortium data collection V: cycles from January to December 2002 with pregnancy follow-up to October 2003</article-title>
          <source>Hum Reprod</source>
          <year>2006</year>
          <volume>21</volume>
          <issue>1</issue>
          <fpage>3</fpage>
          <lpage>21</lpage>
          <pub-id pub-id-type="pmid">16172150</pub-id>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kokkali</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Traeger-Synodinos</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Vrettou</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Stavrou</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>GM</given-names>
            </name>
            <name>
              <surname>Cram</surname>
              <given-names>DS</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Blastocyst biopsy versus cleveage stage biopsy and blastocyst transfer for preimplantation genetic diagnosis of beta-thalassaemia: a pilot study</article-title>
          <source>Hum Reprod</source>
          <year>2007</year>
          <volume>22</volume>
          <issue>5</issue>
          <fpage>1443</fpage>
          <lpage>1449</lpage>
          <pub-id pub-id-type="pmid">17261575</pub-id>
        </element-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>S&#xE1;nchez-Garc&#xED;a</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Benet</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Guti&#xE9;rrez-Mateo</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Lu&#xED;s S&#xE9;culi</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Monr&#xF3;s</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Navarro</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Multiple mutation analysis of the cystic fibrosis gene in single cells</article-title>
          <source>Mol Hum Reprod</source>
          <year>2005</year>
          <volume>11</volume>
          <issue>6</issue>
          <fpage>463</fpage>
          <lpage>468</lpage>
          <pub-id pub-id-type="pmid">15908456</pub-id>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zielenski</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Genotype and phenotype in cystic fibrosis</article-title>
          <source>Respiration</source>
          <year>2000</year>
          <volume>67</volume>
          <issue>2</issue>
          <fpage>117</fpage>
          <lpage>133</lpage>
          <pub-id pub-id-type="pmid">10773783</pub-id>
        </element-citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Field</surname>
              <given-names>PD</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>NJ</given-names>
            </name>
          </person-group>
          <article-title>CFTR mutation screening in an assisted reproductive clinic</article-title>
          <source>Aust N Z J Obstet Gynaecol</source>
          <year>2011</year>
          <volume>51</volume>
          <issue>6</issue>
          <fpage>536</fpage>
          <lpage>539</lpage>
          <pub-id pub-id-type="pmid">21875427</pub-id>
        </element-citation>
      </ref>
      <ref id="B12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ghorbel</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Baklouti-Gargouri</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Keskes</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Sellami-Ben Hamida</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Feki-Chakroun</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Bahloul</surname>
              <given-names>A</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Screening of &#x394;F508 mutation and IVS8-poly T polymorphism in CFTR gene in Tunisian infertile men without CBAVD</article-title>
          <source>Andrologia</source>
          <year>2012</year>
          <volume>44</volume>
          <issue>1</issue>
          <fpage>376</fpage>
          <lpage>382</lpage>
          <pub-id pub-id-type="pmid">21762191</pub-id>
        </element-citation>
      </ref>
      <ref id="B13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alberola</surname>
              <given-names>TM</given-names>
            </name>
            <name>
              <surname>Bautista-Ll&#xE1;cer</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Vendrell</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Garc&#xED;a-Mengual</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Pardo</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Vila</surname>
              <given-names>M</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Case report: birth of healthy twins after preimplantation genetic diagnosis of propionic acidemia</article-title>
          <source>J Assist Reprod Genet</source>
          <year>2011</year>
          <volume>28</volume>
          <issue>3</issue>
          <fpage>211</fpage>
          <lpage>216</lpage>
          <pub-id pub-id-type="pmid">21125326</pub-id>
        </element-citation>
      </ref>
      <ref id="B14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ozge</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Safak</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Ebru</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Evrim</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Bilge</surname>
              <given-names>SE</given-names>
            </name>
            <name>
              <surname>Leyla</surname>
              <given-names>O</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>First successful preimplantation genetic diagnosis of epidermolysis bullosa with pyloric atresia: case study of a novel c.4505-4508insACTC mutation</article-title>
          <source>J Assist Reprod Genet</source>
          <year>2012</year>
          <volume>29</volume>
          <issue>4</issue>
          <fpage>347</fpage>
          <lpage>352</lpage>
          <pub-id pub-id-type="pmid">22354727</pub-id>
        </element-citation>
      </ref>
      <ref id="B15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Taylor</surname>
              <given-names>TH</given-names>
            </name>
            <name>
              <surname>Gilchrist</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Hallowell</surname>
              <given-names>SV</given-names>
            </name>
            <name>
              <surname>Hanshew</surname>
              <given-names>KK</given-names>
            </name>
            <name>
              <surname>Orris</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Glassner</surname>
              <given-names>MJ</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>The effects of different laser pulse lengths on the embryo biopsy procedure and embryo development to the blastocyst stage</article-title>
          <source>J Assist Reprod Genet</source>
          <year>2010</year>
          <volume>27</volume>
          <issue>11</issue>
          <fpage>663</fpage>
          <lpage>667</lpage>
          <pub-id pub-id-type="pmid">20686919</pub-id>
        </element-citation>
      </ref>
      <ref id="B16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Keymolen</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Goossens</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Rycke</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sermon</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Boelaert</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Bonduelle</surname>
              <given-names>M</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Clinical outcome of preimplantation genetic diagnosis for cystic fibrosis: the Brussels&#x2019; experience</article-title>
          <source>Eur J Hum Genet</source>
          <year>2007</year>
          <volume>15</volume>
          <issue>7</issue>
          <fpage>752</fpage>
          <lpage>758</lpage>
          <pub-id pub-id-type="pmid">17440499</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <sub-article id="TRpt" article-type="translation" xml:lang="pt">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Relato De Caso</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Diagn&#xF3;stico gen&#xE9;tico pr&#xE9;-implantacional na fibrose c&#xED;stica: relato de caso</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Biazotti</surname>
            <given-names>Maria Cristina Santoro</given-names>
          </name>
          <xref ref-type="aff" rid="aff1002">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pinto</surname>
            <given-names>Walter</given-names>
            <suffix>Junior</suffix>
          </name>
          <xref ref-type="aff" rid="aff2002">
<sup>2</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Albuquerque</surname>
            <given-names>Maria Cec&#xED;lia Romano Maciel de</given-names>
          </name>
          <xref ref-type="aff" rid="aff3002">
<sup>3</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fujihara</surname>
            <given-names>Litsuko Shimabukuro</given-names>
          </name>
          <xref ref-type="aff" rid="aff4002">
<sup>4</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Suganuma</surname>
            <given-names>Cl&#xE1;udia Haru</given-names>
          </name>
          <xref ref-type="aff" rid="aff5002">
<sup>5</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Reigota</surname>
            <given-names>Renata Bednar</given-names>
          </name>
          <xref ref-type="aff" rid="aff2002">
<sup>2</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bertuzzo</surname>
            <given-names>Carmen S&#xED;lvia</given-names>
          </name>
          <xref ref-type="aff" rid="aff2002">
<sup>2</sup>
</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1002"><label>1</label>Hospital Israelita Albert Einstein, S&#xE3;o Paulo, SP, Brasil.</aff>
      <aff id="aff2002"><label>2</label>Universidade Estadual de Campinas, Campinas, SP, Brasil.</aff>
      <aff id="aff3002"><label>3</label>Centro Cochrane do Brasil, S&#xE3;o Paulo, SP, Brasil.</aff>
      <aff id="aff4002"><label>4</label>Centro de Reprodu&#xE7;&#xE3;o Humana Fertivitro, S&#xE3;o Paulo, SP, Brasil.</aff>
      <aff id="aff5002"><label>5</label> S&#xEA;mion, Centro de Medicina Reprodutiva, Campinas, SP, Brasil.</aff>
      <author-notes>
        <corresp> Autor correspondente: Maria Cristina Santoro Biazotti &#x2212; Avenida Albert Einstein, 627/701 &#x2212; Morumbi &#x2212; CEP: 05652-900 &#x2212; S&#xE3;o Paulo, SP, Brasil &#x2212; Tel.: (11) 2151-9205 &#x2212; E-mail: biazotti@biazotti.com </corresp>
      </author-notes>
      <abstract>
        <p>A fibrose c&#xED;stica &#xE9; uma doen&#xE7;a autoss&#xF4;mica recessiva causada por muta&#xE7;&#xF5;es no gene regulador de condut&#xE2;ncia transmembrana na fibrose c&#xED;stica. Produz fen&#xF3;tipo vari&#xE1;vel, incluindo doen&#xE7;a pulmonar, insufici&#xEA;ncia pancre&#xE1;tica, &#xED;leo meconial, al&#xE9;m de agenesia bilateral dos ductos deferentes, causando azoospermia obstrutiva e infertilidade masculina. O diagn&#xF3;stico gen&#xE9;tico pr&#xE9;-implantacional &#xE9; uma alternativa diagn&#xF3;stica, que permite identificar embri&#xF5;es portadores de fibrose c&#xED;stica e outras doen&#xE7;as gen&#xE9;ticas. Relatamos o caso de um casal portador de fibrose c&#xED;stica, sendo a mulher portadora da muta&#xE7;&#xE3;o I148 T e o homem da muta&#xE7;&#xE3;o g&#xEA;nica Delta F508. O casal foi submetido a t&#xE9;cnicas de fertiliza&#xE7;&#xE3;o <italic>in vitro</italic> associadas ao diagn&#xF3;stico gen&#xE9;tico pr&#xE9;-implantacional, com consequente sele&#xE7;&#xE3;o de embri&#xF5;es saud&#xE1;veis, que foram transferidos para o &#xFA;tero, resultando em gravidez sem intercorr&#xEA;ncias e com feto saud&#xE1;vel, do sexo masculino.</p>
      </abstract>
      <kwd-group>
        <kwd>Fibrose c&#xED;stica</kwd>
        <kwd>Fertiliza&#xE7;&#xE3;o <italic>in vitro</italic></kwd>
        <kwd>Diagn&#xF3;stico gen&#xE9;tico pr&#xE9;-implanta&#xE7;&#xE3;o</kwd>
        <kwd>Relatos de casos</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <sec>
        <title>INTRODU&#xC7;&#xC3;O</title>
        <p>As t&#xE9;cnicas de reprodu&#xE7;&#xE3;o assistida evoluem a cada dia, gra&#xE7;as &#xE0; melhoria nos equipamentos laboratoriais e dos meios para cultivo de gametas e embri&#xF5;es. A introdu&#xE7;&#xE3;o de novas drogas utilizadas na indu&#xE7;&#xE3;o da ovula&#xE7;&#xE3;o, e o aperfei&#xE7;oamento de t&#xE9;cnicas de criopreserva&#xE7;&#xE3;o de gametas e embri&#xF5;es s&#xE3;o parte desse desenvolvimento.</p>
        <p>Com esses avan&#xE7;os, casais portadores ou com antecedente de doen&#xE7;as gen&#xE9;ticas podem ser beneficiados com a fertiliza&#xE7;&#xE3;o <italic>in vitro</italic> (FIV) associada ao diagn&#xF3;stico gen&#xE9;tico pr&#xE9;-implantacional (PGD, <italic>preimplantation genetic diagnosis</italic>), permitindo a sele&#xE7;&#xE3;o de embri&#xF5;es saud&#xE1;veis previamente &#xE0; transfer&#xEA;ncia intrauterina.<sup>(<xref rid="B1" ref-type="bibr">1</xref>)</sup>
</p>
        <sec>
          <title>Diagn&#xF3;stico gen&#xE9;tico pr&#xE9;-implantacional</title>
          <p>O PGD foi desenvolvido com o intuito de fornecer alternativas para o diagn&#xF3;stico pr&#xE9;-natal em casais com risco de transmiss&#xE3;o de doen&#xE7;as gen&#xE9;ticas &#xE0; prole. Esse procedimento pode ser &#xFA;til nos casos de doen&#xE7;as ligadas ao sexo, anomalias cromoss&#xF4;micas e defeitos envolvendo um &#xFA;nico gene.<sup>(<xref rid="B1" ref-type="bibr">1</xref>)</sup>
</p>
          <p>Na realiza&#xE7;&#xE3;o do PGD, os casais devem ser submetidos &#xE0; FIV, mesmo na aus&#xEA;ncia da indica&#xE7;&#xE3;o dessa t&#xE9;cnica (<xref ref-type="fig" rid="f01002">Figura 1</xref>). Para minimizar os riscos de contamina&#xE7;&#xE3;o por c&#xE9;lulas parentais, durante a FIV, recomenda-se o uso da t&#xE9;cnica de inje&#xE7;&#xE3;o intracitoplasm&#xE1;tica de espermatozoides (ICSI, <italic>intra-citoplasmic sperm injection</italic>).<sup>(<xref rid="B2" ref-type="bibr">2</xref>)</sup> Havendo fertiliza&#xE7;&#xE3;o, os embri&#xF5;es permanecem em cultivo, at&#xE9; que uma ou mais c&#xE9;lulas possam ser retiradas e submetidas ao diagn&#xF3;stico gen&#xE9;tico.<sup>(<xref rid="B1" ref-type="bibr">1</xref>)</sup>
</p>
          <p>
<fig id="f01002" orientation="portrait" position="float"><label>Figura 1</label><caption><title>Diagn&#xF3;stico gen&#xE9;tico pr&#xE9;-implantacional</title></caption><graphic xlink:href="1679-4508-eins-13-1-110-gf01-pt"/></fig>
</p>
          <p>Para o PGD, utilizam-se t&#xE9;cnicas baseadas na rea&#xE7;&#xE3;o em cadeia da polimerase (PCR) e na citogen&#xE9;tica molecular. Por muito tempo utilizada, a t&#xE9;cnica de hibridiza&#xE7;&#xE3;o <italic>in situ</italic> fluorescente (FISH) vem sendo substitu&#xED;da pela hibridiza&#xE7;&#xE3;o comparativa do genoma em <italic>arrays</italic> (aCGH, <italic>Array-Comparative Genomic Hybridization</italic>),<sup>(<xref rid="B3" ref-type="bibr">3</xref>,<xref rid="B4" ref-type="bibr">4</xref>)</sup> que analisa amplifica&#xE7;&#xF5;es e dele&#xE7;&#xF5;es espec&#xED;ficas do genoma, permitindo detectar ganhos e perdas de material gen&#xE9;tico em regi&#xF5;es espec&#xED;ficas do genoma com alta resolu&#xE7;&#xE3;o (dez a cem vezes maior que as t&#xE9;cnicas tradicionais),<sup>(<xref rid="B5" ref-type="bibr">5</xref>)</sup> dependendo da plataforma de an&#xE1;lise utilizada. Al&#xE9;m disso, aCGH permite um estudo mais acurado das anomalias cromoss&#xF4;micas e dele&#xE7;&#xF5;es ou rearranjos gen&#xE9;ticos do que o FISH.</p>
        </sec>
        <sec>
          <title>Bi&#xF3;psia de embri&#xE3;o</title>
          <p>A bi&#xF3;psia de embri&#xE3;o consiste na remo&#xE7;&#xE3;o de uma ou mais c&#xE9;lulas do embri&#xE3;o pr&#xE9;-implanta&#xE7;&#xE3;o para subsequente estudo gen&#xE9;tico. O primeiro caso de PGD em humanos foi relatado por Handyside et al.<sup>(<xref rid="B6" ref-type="bibr">6</xref>)</sup>
</p>
          <p>Ap&#xF3;s t&#xE9;cnica de ICSI, os embri&#xF5;es s&#xE3;o cultivados at&#xE9; o 3&#xBA; dia de clivagem, podendo o cultivo se prolongar at&#xE9; a fase de blastocisto (5&#xBA;/6&#xBA; dia de cultivo) para, ent&#xE3;o, serem submetidos &#xE0; bi&#xF3;psia, sem que haja preju&#xED;zo &#xE0; implanta&#xE7;&#xE3;o ou ao desenvolvimento gestacional.<sup>(<xref rid="B6" ref-type="bibr">6</xref>)</sup> A bi&#xF3;psia &#xE9; mais frequentemente realizada no 3&#xBA; dia de desenvolvimento embrion&#xE1;rio (est&#xE1;gio de seis a oito c&#xE9;lulas), sendo que um ou dois blast&#xF4;meros &#xE9; retirado de cada embri&#xE3;o<sup>(<xref rid="B7" ref-type="bibr">7</xref>)</sup>(<xref ref-type="fig" rid="f02002">Figura 2</xref>). Uma das vantagens ao postergar a biopsia de embri&#xF5;es at&#xE9; o est&#xE1;gio de blastocisto &#xE9; a possibilidade de obten&#xE7;&#xE3;o de maior n&#xFA;mero de c&#xE9;lulas (trofoderma) para a realiza&#xE7;&#xE3;o da an&#xE1;lise gen&#xE9;tica, aumentado o n&#xFA;mero de c&#xF3;pias de DNA e a acur&#xE1;cia no diagnostico.<sup>(<xref rid="B8" ref-type="bibr">8</xref>)</sup>
</p>
          <p>
<fig id="f02002" orientation="portrait" position="float"><label>Figura 2</label><caption><title>Bi&#xF3;psia</title></caption><graphic xlink:href="1679-4508-eins-13-1-110-gf02-pt"/></fig>
</p>
        </sec>
        <sec>
          <title>Fibrose c&#xED;stica</title>
          <p>A fibrose c&#xED;stica (FC) &#xE9; uma doen&#xE7;a autoss&#xF4;mica recessiva causada por muta&#xE7;&#xF5;es no gene regulador de condut&#xE2;ncia transmembrana na fibrose c&#xED;stica (CFTR, <italic>cystic fibrosis transmembrane conductance regulator</italic>) e afeta 1 a cada 2.500 rec&#xE9;m-nascidos.<sup>(<xref rid="B9" ref-type="bibr">9</xref>)</sup> Esse gene codifica uma prote&#xED;na expressa na membrana apical das c&#xE9;lulas epiteliais ex&#xF3;crinas.<sup>(<xref rid="B10" ref-type="bibr">10</xref>)</sup> Muta&#xE7;&#xF5;es no gene CFTR produzem um fen&#xF3;tipo vari&#xE1;vel, incluindo doen&#xE7;a pulmonar, insufici&#xEA;ncia pancre&#xE1;tica, &#xED;leo mec&#xF4;nio<sup>(<xref rid="B11" ref-type="bibr">11</xref>)</sup> e tamb&#xE9;m est&#xE3;o envolvidas na agenesia bilateral dos ductos deferentes, causando azoospermia obstrutiva e infertilidade masculina<sup>(<xref rid="B12" ref-type="bibr">12</xref>)</sup> (<xref ref-type="fig" rid="f03002">Figura 3</xref>).</p>
          <p>
<fig id="f03002" orientation="portrait" position="float"><label>Figura 3</label><caption><title>Fibrose c&#xED;stica</title></caption><graphic xlink:href="1679-4508-eins-13-1-110-gf03-pt"/></fig>
</p>
        </sec>
      </sec>
      <sec>
        <title>RELATO DE CASO</title>
        <p>Relatamos aqui o caso de paciente do g&#xEA;nero feminino, 33 anos, sem filhos, inicialmente avaliada em 25 de mar&#xE7;o de 2004, com dificuldade para engravidar havia 2 anos. Referia menarca aos 11 anos, ciclo menstrual regular e antecedente materno de neoplasia maligna de mama. Apresentava, &#xE0; ultrassonografia transvaginal, cisto simples paratub&#xE1;rio &#xE0; esquerda e imagem sugestiva de cisto dermoide &#xE0; direita (16,0 x 12,0mm de di&#xE2;metro), est&#xE1;veis havia 12 meses. Os exames laboratoriais e as pesquisas para fungo e bact&#xE9;rias, na secre&#xE7;&#xE3;o vaginal, foram normais. A paciente era sabidamente portadora da muta&#xE7;&#xE3;o I148 T para FC.</p>
        <p>A paciente era casada h&#xE1; 12 anos. Seu parceiro de 33 anos apresentava acentuada oligospermia e diagn&#xF3;stico de varicocele. Ap&#xF3;s corre&#xE7;&#xE3;o cir&#xFA;rgica, evoluiu com melhora dos par&#xE2;metros seminais, cuja concentra&#xE7;&#xE3;o aumentou de 0,75 milh&#xF5;es/mL para 5,48 milh&#xF5;es/mL. O paciente era portador da muta&#xE7;&#xE3;o g&#xEA;nica Delta F508 para FC.</p>
        <p>A paciente foi submetida &#xE0; FIV/ICSI em setembro de 2004, com obten&#xE7;&#xE3;o de sete embri&#xF5;es, dos quais tr&#xEA;s foram transferidos para o &#xFA;tero da paciente e quatro congelados. O teste de gravidez foi positivo em 22 de outubro de 2004, e a ultrassonografia transvaginal evidenciou um saco gestacional compat&#xED;vel com gesta&#xE7;&#xE3;o de 5 semanas. Em 10 de dezembro, com 11&#xAA; semanas de gesta&#xE7;&#xE3;o, foi submetida &#xE0; bi&#xF3;psia de vilo corial confirmando sexo masculino. Para avalia&#xE7;&#xE3;o da muta&#xE7;&#xE3;o Delta F508, foi realizada PCR e eletroforese em gel de poliacrilamida a 12%. Para pesquisa da muta&#xE7;&#xE3;o I148 T, foi realizada PCR com <italic>primers</italic> envolvendo o &#xE9;xon 4. Em seguida, procedeu-se &#xE0; digest&#xE3;o enzim&#xE1;tica com enzima Bsrl. Dessa forma, ficou comprovado tratar-se de embri&#xE3;o portador de FC.</p>
        <p>A paciente evoluiu para abortamento e foi submetida &#xE0; curetagem uterina em maio de 2005. Logo ap&#xF3;s, perdeu seguimento por 5 meses.</p>
        <p>Observou-se que o casal apresentava os polimorfismos TUB18 e KM19, os quais possibilitariam a identifica&#xE7;&#xE3;o de alelos mutantes em gesta&#xE7;&#xF5;es futuras, aumentando, assim, o poder de detec&#xE7;&#xE3;o do embri&#xE3;o afetado.</p>
        <p>Em abril de 2006, a paciente foi submetida &#xE0; histeroscopia para ressec&#xE7;&#xE3;o de septo uterino secund&#xE1;rio &#xE0; curetagem pr&#xE9;via. Reiniciou o uso de an&#xE1;logo do GnRH em maio de 2006, al&#xE9;m de antibi&#xF3;tico e polivitam&#xED;nico. Entretanto, teve m&#xE1; resposta ao bloqueio do eixo hipot&#xE1;lamo-hipofis&#xE1;rio.</p>
        <p>Na etapa seguinte, optou-se por ciclo natural, com obten&#xE7;&#xE3;o de fol&#xED;culo de 19,0mm de di&#xE2;metro em ov&#xE1;rio direito e endom&#xE9;trio trilaminar, com 10,0mm de espessura &#xE0; ultrassonografia transvaginal, realizada em 31 de agosto de 2006.</p>
        <p>Os quatro embri&#xF5;es previamente congelados foram biopsiados, utilizando-se a t&#xE9;cnica de laser para perfura&#xE7;&#xE3;o da zona pel&#xFA;cida, e, ent&#xE3;o, os blast&#xF4;meros foram submetidos &#xE0; avalia&#xE7;&#xE3;o gen&#xE9;tica. N&#xE3;o houve amplifica&#xE7;&#xE3;o de <italic>primers</italic> no primeiro embri&#xE3;o, n&#xE3;o sendo poss&#xED;vel a pesquisa das muta&#xE7;&#xF5;es. O segundo blast&#xF4;mero era portador de ambas as muta&#xE7;&#xF5;es e, desse modo, portador de FC. O terceiro apresentou apenas a muta&#xE7;&#xE3;o I148 T e o quarto blast&#xF4;mero n&#xE3;o apresentou nenhuma das muta&#xE7;&#xF5;es estudadas. O terceiro e o quarto embri&#xF5;es foram, ent&#xE3;o, transferidos no dia 5 de setembro de 2006. Ecografia realizada em 6 de novembro de 2006 evidenciou gesta&#xE7;&#xE3;o compat&#xED;vel com 11 semanas e 5 dias pela biometria e feto com transluc&#xEA;ncia nucal dentro da normalidade. Em 10 de maio de 2007, a paciente foi submetida &#xE0; cesariana, dando &#xE0; luz um rec&#xE9;m-nascido do sexo masculino, com 3.320g e Apgar 8/10, sem intercorr&#xEA;ncias. Amamentou durante 2 meses e retornou &#xE0; cl&#xED;nica 11 meses ap&#xF3;s o parto. &#xC0; ocasi&#xE3;o, a crian&#xE7;a apresentava poliglobulia e eosinofilia aos exames laboratoriais, sem quaisquer outras altera&#xE7;&#xF5;es ou queixas.</p>
      </sec>
      <sec>
        <title>DISCUSS&#xC3;O</title>
        <p>Nas doen&#xE7;as autoss&#xF4;micas recessivas, cada um dos pais da crian&#xE7;a afetada &#xE9; portador de uma &#xFA;nica c&#xF3;pia do alelo mutado. Em cada concep&#xE7;&#xE3;o, a possibilidade da crian&#xE7;a nascer com a doen&#xE7;a &#xE9; 25%. Os portadores s&#xE3;o assintom&#xE1;ticos e os casais somente t&#xEA;m consci&#xEA;ncia do problema quando j&#xE1; tiverem filhos afetados, algum parente acometido pela doen&#xE7;a ou se houve investiga&#xE7;&#xE3;o pr&#xE9;via do casal.<sup>(<xref rid="B13" ref-type="bibr">13</xref>)</sup> Por essa raz&#xE3;o, o PGD, associado &#xE0; FIV/ICSI, parece ser a &#xFA;nica maneira de evitar a recorr&#xEA;ncia.<sup>(<xref rid="B14" ref-type="bibr">14</xref>)</sup>
</p>
        <p>Taylor et al<italic>. </italic>conclu&#xED;ram que o laser n&#xE3;o influenciou o procedimento de bi&#xF3;psia e nem afetou o desenvolvimento embrion&#xE1;rio.<sup>(<xref rid="B15" ref-type="bibr">15</xref>)</sup> Keymolen et al., em estudo realizado ao longo de 11 anos no Centro de Gen&#xE9;tica M&#xE9;dica, na B&#xE9;lgica, relataram PGD em embri&#xF5;es de 47 casais, sendo a FC a indica&#xE7;&#xE3;o mais frequente desses procedimentos (55% dos casos). No total, 461 embri&#xF5;es foram submetidos &#xE0; bi&#xF3;psia e, ao final do estudo, dentre os 25 rec&#xE9;m-nascidos, n&#xE3;o houve nenhum diagn&#xF3;stico de FC.<sup>(<xref rid="B16" ref-type="bibr">16</xref>)</sup>
</p>
        <p>Neste relato, descrevemos o caso de PGD com nascimento de beb&#xEA; saud&#xE1;vel cujo casal apresentava risco de transmiss&#xE3;o heredit&#xE1;ria de FC. A esposa era portadora da muta&#xE7;&#xE3;o I148 T para FC e seu marido era portador da muta&#xE7;&#xE3;o g&#xEA;nica Delta F508 para a mesma doen&#xE7;a. O casal foi submetido a procedimento de FVI/ICSI, vitrifica&#xE7;&#xE3;o e desvitrifica&#xE7;&#xE3;o de embri&#xF5;es, PGD e transfer&#xEA;ncia embrion&#xE1;ria. Houve confirma&#xE7;&#xE3;o de gravidez, que ocorreu sem intercorr&#xEA;ncias, com nascimento de um menino por parto ces&#xE1;rea.</p>
        <p>Em conclus&#xE3;o, o uso do PGD foi eficiente para a detec&#xE7;&#xE3;o de FC nos embri&#xF5;es avaliados. Essa experi&#xEA;ncia positiva serve de incentivo para o uso mais frequente dessa t&#xE9;cnica e, tamb&#xE9;m, estimula o desenvolvimento de protocolos de PGD para muitas outras doen&#xE7;as gen&#xE9;ticas.</p>
      </sec>
    </body>
  </sub-article>
</article>
</pmc-articleset>
